KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $40.2 million.

  • Hims & Hers Health's Share-based Compensation rose 6133.98% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.1 million, marking a year-over-year increase of 4587.12%. This contributed to the annual value of $92.3 million for FY2024, which is 3971.25% up from last year.
  • Latest data reveals that Hims & Hers Health reported Share-based Compensation of $40.2 million as of Q3 2025, which was up 6133.98% from $35.7 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Share-based Compensation ranged from a high of $40.2 million in Q3 2025 and a low of $8.9 million during Q1 2022
  • Its 5-year average for Share-based Compensation is $19.4 million, with a median of $17.3 million in 2023.
  • In the last 5 years, Hims & Hers Health's Share-based Compensation soared by 233803.42% in 2021 and then plummeted by 7412.8% in 2022.
  • Hims & Hers Health's Share-based Compensation (Quarter) stood at $12.0 million in 2021, then rose by 3.33% to $12.4 million in 2022, then skyrocketed by 44.06% to $17.8 million in 2023, then soared by 36.86% to $24.3 million in 2024, then skyrocketed by 64.98% to $40.2 million in 2025.
  • Its Share-based Compensation stands at $40.2 million for Q3 2025, versus $35.7 million for Q2 2025 and $24.9 million for Q1 2025.